Performance of Abiraterone and enzalutamide in metastatic castration-resistant prostate cancer men: A head to head comparison based on a 2014-2017 French population study - Archive ouverte HAL Access content directly
Journal Articles Pharmacoepidemiology and Drug Safety Year : 2019

Performance of Abiraterone and enzalutamide in metastatic castration-resistant prostate cancer men: A head to head comparison based on a 2014-2017 French population study

Domains

Life Sciences [q-bio] Bioengineering

Laurent Jonchère  : Connect in order to contact the contributor

https://hal-univ-rennes1.archives-ouvertes.fr/hal-02302411

Submitted on : Tuesday, October 1, 2019-2:58:49 PM

Last modification on : Thursday, March 16, 2023-3:10:09 PM

Not file

Dates and versions

hal-02302411 , version 1 (01-10-2019)

Identifiers

  • HAL Id : hal-02302411 , version 1

Cite

Lucie-Marie Scailteux, Boris Campillo-Gimenez, Sandrine Kerbrat, Fabien Despas, Sebastien Vincendeau, et al.. Performance of Abiraterone and enzalutamide in metastatic castration-resistant prostate cancer men: A head to head comparison based on a 2014-2017 French population study. Pharmacoepidemiology and Drug Safety, 2019, 28, pp.128-128. ⟨hal-02302411⟩

Export

BibTeX TEI Dublin Core DC Terms EndNote Datacite

Collections

UNIV-RENNES1 LTSI UR1-UFR-SVE UR1-MATH-STIC REPERES UNIV-RENNES UR1-MATH-NUM UR1-BIO-SA UNIV-UT3 UT3-TOULOUSEINP
63 View
0 Download

Share

Gmail Facebook Twitter LinkedIn More